Genovis AB (publ.) (STO: GENO)
Sweden
· Delayed Price · Currency is SEK
24.50
-0.40 (-1.61%)
Jan 20, 2025, 2:59 PM CET
Genovis AB (publ.) Revenue
Genovis AB (publ.) had revenue of 32.90M SEK in the quarter ending September 30, 2024, with 8.97% growth. This brings the company's revenue in the last twelve months to 130.57M, down -17.28% year-over-year. In the year 2023, Genovis AB (publ.) had annual revenue of 159.07M with 53.60% growth.
Revenue (ttm)
130.57M
Revenue Growth
-17.28%
P/S Ratio
11.81
Revenue / Employee
4.08M
Employees
37
Market Cap
1.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
Dec 31, 2019 | 60.55M | 25.98M | 75.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 25.44B |
Getinge AB | 33.59B |
Sectra AB | 3.14B |
Camurus AB | 1.69B |
Medicover AB | 22.60B |
Vitrolife AB | 3.56B |
Bonesupport Holding AB | 814.46M |
Elekta AB | 17.72B |
Genovis AB (publ.) News
- 2 months ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus